Mxil, a Myc antagonist, suppresses proliferation of DU145 human prostate cells

被引:41
作者
Taj, MM
Tawil, RJ
Engstrom, LD
Zeng, Z
Hwang, C
Sanda, MG
Wechsler, DS
机构
[1] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Div Pediat Hematol Oncol, Ann Arbor, MI USA
[2] Univ Michigan, Sch Med, Dept Surg, Div Urol, Ann Arbor, MI USA
关键词
prostate cancer; chromosome; 10; c-Myc; adenovirus; G(2)/M arrest;
D O I
10.1002/pros.1063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Mxi1, an antagonist of c-Myc, maps to human chromosome 10q24-q25, a region altered in a substantial fraction of prostate tumors. Mice deficient for Mail exhibit significant prostate hyperplasia. We studied the ability of Mxi1 to act as a growth suppressor in prostate tumor cells. METHODS. We infected DU145 prostate carcinoma cells with an Mxi1-expressing adenovirus (AdMxi1) in vitro, and measured Mxi1 expression, cell proliferation, soft agar colony formation, and cell cycle distribution. To explore mechanisms of Mxi1-induced growth arrest, we performed gene expression analysis. RESULTS. AdMxi1 infection resulted in reduced cell proliferation, reduced soft agar colony formation: and a higher proportion of cells in the G(2)/M phase of the cell cycle. This G(2)/M growth arrest was associated with elevated levels of cyclin B, and reduced levels of c-MYC and MDM2. CONCLUSIONS. The ability of AdMxi1 to suppress prostate tumor cell proliferation supports a role for Mxi1 loss in the pathogenesis of a subset of human prostate canters. Prostate 47:194-204, 2001. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 61 条
[1]   Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression [J].
Alland, L ;
Muhle, R ;
Hou, H ;
Potes, J ;
Chin, L ;
SchreiberAgus, N ;
DePinho, RA .
NATURE, 1997, 387 (6628) :49-55
[2]  
[Anonymous], GENETIC BASIS HUMAN
[3]  
Asadi F. K., 1995, International Urology and Nephrology, V27, P67
[4]   MAD - A HETERODIMERIC PARTNER FOR MAX THAT ANTAGONIZES MYC TRANSCRIPTIONAL ACTIVITY [J].
AYER, DE ;
KRETZNER, L ;
EISENMAN, RN .
CELL, 1993, 72 (02) :211-222
[5]   Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer [J].
Balaji, KC ;
Koul, H ;
Mitra, S ;
Maramag, C ;
Reddy, P ;
Menon, M ;
Malhotra, RK ;
Laxmanan, S .
UROLOGY, 1997, 50 (06) :1007-1015
[6]   Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization [J].
Bernardino, J ;
Bourgeois, CA ;
Muleris, M ;
Dutrillaux, AM ;
Malfoy, B ;
Dutrillaux, B .
CANCER GENETICS AND CYTOGENETICS, 1997, 96 (02) :123-128
[7]  
BROTHMAN AR, 1990, CANCER RES, V50, P3795
[8]   ENHANCED EXPRESSION OF THE C-MYC PROTOONCOGENE IN HIGH-GRADE HUMAN-PROSTATE CANCERS [J].
BUTTYAN, R ;
SAWCZUK, IS ;
BENSON, MC ;
SIEGAL, JD ;
OLSSON, CA .
PROSTATE, 1987, 11 (04) :327-337
[9]   ALLELIC LOSS OF CHROMOSOME-16Q AND CHROMOSOME-10Q IN HUMAN PROSTATE-CANCER [J].
CARTER, BS ;
EWING, CM ;
WARD, WS ;
TREIGER, BF ;
AALDERS, TW ;
SCHALKEN, JA ;
EPSTEIN, JI ;
ISAACS, WB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8751-8755
[10]   EFFECTS OF THE MYC ONCOGENE ANTAGONIST, MAD, ON PROLIFERATION, CELL CYCLING AND THE MALIGNANT PHENOTYPE OF HUMAN BRAIN-TUMOR CELLS [J].
CHEN, J ;
WILLINGHAM, T ;
MARGRAF, LR ;
SCHREIBERAGUS, N ;
DEPINHO, RA ;
NISEN, PD .
NATURE MEDICINE, 1995, 1 (07) :638-643